Victoria C Cogger

Dr. Victoria C Cogger


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
SSSamantha M. Solon-Biet
Samantha M. Solon-Biet
VCVictoria C Cogger
Victoria C Cogger
TPTamara Pulpitel
Tamara Pulpitel
DWDevin Wahl
Devin Wahl
XCXimonie Clark
Ximonie Clark
SSStephen J. Simpson
Stephen J. Simpson

1 January 2019 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
NHNicholas Hunt
Nicholas Hunt
SKSun Woo (Sophie) Kang
Sun Woo (Sophie) Kang
GLGlen P. Lockwood
Glen P. Lockwood
DCDavid G. Le Couteur
David G. Le Couteur
VCVictoria C Cogger
Victoria C Cogger
While the liver demonstrates remarkable resilience during aging, there is growing evidence that it undergoes all the cellular hallmarks of aging, which increases the risk of liver and systemic disease. The aging process in the liver is driven by alterations of the genome and epigenome that contribute to dysregulation of mitochondrial function and nutrient sensing pathways, leading to cellular senescence and low-grade inflammation. These changes promote multiple phenotypic changes in all liver cells (hepatocytes, liver sinusoidal endothelial, hepatic stellate and Küpffer cells) and impairment of hepatic function. In particular, age-related changes in the liver sinusoidal endothelial cells are a significant but under-recognized risk factor for the development of age-related cardiometabolic disease.

1 September 2010 in Journal of Structural Biology
Verified
Journal Article
Closed access
VCVictoria C Cogger
Victoria C Cogger
GMGregory P. McNerney
Gregory P. McNerney
TNTun Nyunt
Tun Nyunt
LDLaurie D. DeLeve
Laurie D. DeLeve
PMPeter McCourt
Peter McCourt
THThomas Huser
Thomas Huser

8 June 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
JWJibran Wali
Jibran Wali
AMAnnabelle J. Milner
Annabelle J. Milner
ALAlison Luk
Alison Luk
TPTamara J. Pulpitel
Tamara J. Pulpitel
TDTim Dodgson
Tim Dodgson
SSStephen J. Simpson
Stephen J. Simpson

2 January 2024 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
NHNicholas Hunt
Nicholas Hunt
GLGlen Lockwood
Glen Lockwood
SHScott J. Heffernan
Scott J. Heffernan
JDJarryd Daymond
Jarryd Daymond
MNMeng Ngu
Meng Ngu
VCVictoria C Cogger
Victoria C Cogger
Injectable insulin is an extensively used medication with potential life-threatening hypoglycaemic events. Here we report on insulin-conjugated silver sulfide quantum dots coated with a chitosan/glucose polymer to produce a responsive oral insulin nanoformulation. This formulation is pH responsive, is insoluble in acidic environments and shows increased absorption in human duodenum explants and Caenorhabditis elegans at neutral pH. The formulation is sensitive to glucosidase enzymes to trigger insulin release. It is found that the formulation distributes to the liver in mice and rats after oral administration and promotes a dose-dependent reduction in blood glucose without promoting hypoglycaemia or weight gain in diabetic rodents. Non-diabetic baboons also show a dose-dependent reduction in blood glucose. No biochemical or haematological toxicity or adverse events were observed in mice, rats and non-human primates. The formulation demonstrates the potential to orally control blood glucose without hypoglycaemic episodes.

28 July 2025 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
DCDavid G. Le Couteur
David G. Le Couteur
MNMeng C. Ngu
Meng C. Ngu
NHNicholas Hunt
Nicholas Hunt
ABAmanda E. Brandon
Amanda E. Brandon
SSStephen J. Simpson
Stephen J. Simpson
VCVictoria C Cogger
Victoria C Cogger